Clinical Trial Update: Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bortezomib with ACVBP in peripheral T-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• ACVBP
• Bortezomib (bortezomib)

Snippet

Sponsor: Lymphoma Study Association | Conditions: Peripheral T-cell Lymphoma | Phase 2 | Status: COMPLETED